Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 1Neoplasms 1Inflammation 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Autoimmune Diseases 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Oxycodone 2Omeprazole 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Dexmedetomidine 2Blood Specimen Collection 2Aspirin 2ziprasidone 1soybean oil, phospholipid emulsion 1semaglutide 1montelukast 1microcrystalline cellulose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Inflammation × Ashwagandha × Clear all
NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

National University of Natural Medicine

Phase 1 Completed
25 enrolled

Autoimmune Diseases, Inflammation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡